Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 16, 2021
Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
Vahid Shaygannejad, Omid Mirmosayyeb, Nasim Nehzat, et al.
Autoimmunity Reviews
|
December 19, 2020
Efficacy and safety of rituximab in treating patients with Neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
Omid Mirmosayyeb, Vahid Shaygannejad, Mahdi Barzegar, et al.
International Journal of Preventive Medicine
|
June 4, 2021
Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis
Omid Mirmosayyeb, Vahid Shaygannejad, Nasim Nehzat, et al.
Current Journal of Neurology
|
November 27, 2023
Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?
Omid Mirmosayyeb, Mahdi Barzegar, Nasim Nehzat, et al.
Neurology Research International
|
August 2, 2021
Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
Nasim Nehzat, Omid Mirmosayyeb, Mahdi Barzegar, et al.
Multiple Sclerosis and Related Disorders
|
December 15, 2020
Frequency of comorbidities in Neuromyelitis Optica spectrum disorder
Mahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
October 19, 2020
The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis
Omid Mirmosayyeb, Mahdi Barzegar, Nasim Nehzat, et al.
Multiple Sclerosis and Related Disorders
|
May 12, 2021
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
Mahdi Barzegar, Saeed Vaheb, Omid Mirmosayyeb, et al.
Multiple Sclerosis and Related Disorders
|
July 3, 2021
Early predictors of conversion to secondary progressive multiple sclerosis
Mahdi Barzegar, Soroush Najdaghi, Alireza Afshari-Safavi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 7, 2020
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Mahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 16, 2021
Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
Vahid Shaygannejad, Omid Mirmosayyeb, Nasim Nehzat, et al.
Autoimmunity Reviews
|
December 19, 2020
Efficacy and safety of rituximab in treating patients with Neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
Omid Mirmosayyeb, Vahid Shaygannejad, Mahdi Barzegar, et al.
International Journal of Preventive Medicine
|
June 4, 2021
Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis
Omid Mirmosayyeb, Vahid Shaygannejad, Nasim Nehzat, et al.
Current Journal of Neurology
|
November 27, 2023
Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?
Omid Mirmosayyeb, Mahdi Barzegar, Nasim Nehzat, et al.
Neurology Research International
|
August 2, 2021
Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
Nasim Nehzat, Omid Mirmosayyeb, Mahdi Barzegar, et al.
Multiple Sclerosis and Related Disorders
|
December 15, 2020
Frequency of comorbidities in Neuromyelitis Optica spectrum disorder
Mahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
October 19, 2020
The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis
Omid Mirmosayyeb, Mahdi Barzegar, Nasim Nehzat, et al.
Multiple Sclerosis and Related Disorders
|
May 12, 2021
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
Mahdi Barzegar, Saeed Vaheb, Omid Mirmosayyeb, et al.
Multiple Sclerosis and Related Disorders
|
July 3, 2021
Early predictors of conversion to secondary progressive multiple sclerosis
Mahdi Barzegar, Soroush Najdaghi, Alireza Afshari-Safavi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 7, 2020
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Mahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, et al.
Page
of 3